Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

PHARMACARE achieves net income of $1.64 million in 9M 2013

2013-11-03

According to Dar Al-Shifa Pharmaceuticals Company (PHARMACARE)’s data for the first nine months of the year, net profit after taxes reached 1,638,596 USD, PHARMACARE was listed on the PEX on April 23rd, 2012, and income for the prior similar reporting period has not been disclosed. Total assets of the company reached 35,385,469 USD as of September 30th, 2013, compared to total assets of 29,876,871 USD as of December 31st, 2012, a net increase of 18.4%. Total liabilities of the company reached 15,306,643 USD as of September 30th, 2013, compared to total liabilities of 10,932,921 USD as of December 31st, 2012, a net increase of 40.0%. Net ownership equity of the company reached 20,078,826 USD as of September 30th, 2013, compared with net ownership equity of 18,943,950 USD as of December 31st, 2012, a net increase of 6.0 in the first nine months.

 


 

2021-10-24
ARAB posts net income of JD0.02 million in 9M 2021

2021-10-21
Al-Quds Index in a narrow range amid an increase in 9M financial data disclosures anticipation

2021-10-17
PHARMACARE recommends distributing 10% cash dividends for the year 2020

2021-10-14
A transaction on the stocks of TRSUT raises the trading value in the PEX

2021-10-07
Al-Quds Index rebounds upwards in the first week of October

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013